Adrian Hall
UCB Pharma (Belgium)(BE)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Asymmetric Synthesis and Catalysis, Catalytic C–H Functionalization Methods, Synthesis and Biological Evaluation, Alzheimer's disease research and treatments
Most-Cited Works
- → One‐Pot, Three‐Component Sulfonimidamide Synthesis Exploiting the Sulfinylamine Reagent N‐Sulfinyltritylamine, TrNSO(2017)126 cited
- → Harnessing Sulfinyl Nitrenes: A Unified One-Pot Synthesis of Sulfoximines and Sulfonimidamides(2020)108 cited
- → Total Synthesis and Structural Confirmation of the Marine Natural Product Dysinosin A: A Novel Inhibitor of Thrombin and Factor VIIa(2002)91 cited
- → A General Method for the α-Acyloxylation of Carbonyl Compounds(2005)85 cited
- → Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy(2008)76 cited
- → Photocatalytic Late-Stage Functionalization of Sulfonamides via Sulfonyl Radical Intermediates(2022)75 cited
- → Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation(2018)68 cited
- → Lipopolysaccharide Induction of Tissue Factor in THP-1 Cells Involves Jun Protein Phosphorylation and Nuclear Factor κB Nuclear Translocation(1999)61 cited
- → Primary Sulfonamide Synthesis Using the Sulfinylamine Reagent N-Sulfinyl-O-(tert-butyl)hydroxylamine, t-BuONSO(2020)61 cited
- → Copper-Catalyzed Coupling of Hydroxylamines with Aryl Iodides(2008)58 cited